Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 211832
Company: TWI PHARMS

Products on ANDA 211832

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	2.5MG	TABLET;ORAL	Prescription	AB	No	No
TERBUTALINE SULFATE	TERBUTALINE SULFATE	5MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 211832

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
06/19/2020	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 211832

TERBUTALINE SULFATE

TABLET;ORAL; 2.5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BRETHINE	TERBUTALINE SULFATE	2.5MG	TABLET;ORAL	Prescription	Yes	AB	017849	ANI PHARMS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	2.5MG	TABLET;ORAL	Prescription	No	AB	075877	IMPAX LABS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	2.5MG	TABLET;ORAL	Prescription	No	AB	077152	LANNETT CO INC
TERBUTALINE SULFATE	TERBUTALINE SULFATE	2.5MG	TABLET;ORAL	Prescription	No	AB	211832	TWI PHARMS

TABLET;ORAL; 5MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
BRETHINE	TERBUTALINE SULFATE	5MG	TABLET;ORAL	Prescription	Yes	AB	017849	ANI PHARMS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	5MG	TABLET;ORAL	Prescription	No	AB	075877	IMPAX LABS
TERBUTALINE SULFATE	TERBUTALINE SULFATE	5MG	TABLET;ORAL	Prescription	No	AB	077152	LANNETT CO INC
TERBUTALINE SULFATE	TERBUTALINE SULFATE	5MG	TABLET;ORAL	Prescription	No	AB	211832	TWI PHARMS